Bausch + Lomb Corporation (BLCO)

$17.11

-0.09 (-0.52%)
Rating:
Recommendation:
-
Symbol BLCO
Price $17.11
Beta 0.000
Volume Avg. 0.42M
Market Cap 5.989B
Shares () -
52 Week Range 12.2-20.2
1y Target Est -
DCF Unlevered BLCO DCF ->
DCF Levered BLCO LDCF ->
ROE 0.65% Neutral
ROA 0.53% Neutral
Operating Margin -
Debt / Equity 51.69% Buy
P/E 100.65 Strong Buy
P/B 0.84 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BLCO news


Healthcare
Medical Instruments & Supplies
New York Stock Exchange

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.